Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,287.20
(
-0.64%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
99.06
(
-0.80%
)
Bitcoin
70,854.99
(
0.11%
)
News Focus
News Focus
Post# of 300
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MahinAgency

Send PM Follow Ignore
Followers 29
Posts 617
Boards Moderated 0
Alias Born 08/25/2023

MahinAgency

Re: Tiger Money post# 188

Friday, 10/25/2024 12:42:40 PM

Friday, October 25, 2024 12:42:40 PM

Post# of 300
NASDAQ: $CRDL H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics (CRDL) with a price target of $9.00.

CardiolRx could serve as an earlier treatment alternative, competing with Arcalyst, which costs $300,000 annually.
Bullish
Bullish
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CRDL News
More CRDL News